Aurore Perrot

80PUBLICATIONS
204CO-AUTHORS
Ngā rongoā me ngā whakamaimoa o te Māori (Māori medicine and treatments)Medical mycologyPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (80)

|Aug 24, 2026
Daratumumab, lenalidomide, and dexamethasone in transplant-ineligible newly diagnosed multiple myeloma: MAIA final survival analysis.

|Aug 17, 2026
Blood-based MALDI-TOF mass spectrometry versus bone marrow MRD for monitoring multiple myeloma: CASSIOPEIA study results.

|Jul 02, 2026
Expression profile of CASSIOPEIA patients refines prognostic value of MRD negativity in multiple myeloma.

|Jun 15, 2026
Talquetamab-Daratumumab in Relapsed or Refractory Myeloma.

|Jun 08, 2026
Outpatient Rescue With Stem Cells Boost for Refractory Hematotoxicity Following anti-BCMA CAR T-Cell Therapy: A Case Report.

|Jun 03, 2026
Daratumumab in transplant-ineligible or -deferred newly diagnosed multiple myeloma: minimal residual disease in CEPHEUS.

Pageof 14

Frequent Collaborators

31 joint publications

Jill Corre

25 joint publications

Xavier P Leleu

15 joint publications

Philippe Moreau

10 joint publications

Mohamad Mohty